Phase I/II Study of a Five-fraction Hypofractionated Accelerated Radiotherapy Treatment for Low-risk Localised Prostate Cancer: Early Results of pHART3
- 1 December 2008
- journal article
- Published by Elsevier BV in Clinical Oncology
- Vol. 20 (10), 729-737
- https://doi.org/10.1016/j.clon.2008.08.006
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and TreatmentJournal of Urology, 2007
- Hypofractionation in Clinical Trials for Prostate CancerClinical Oncology, 2007
- Is the α/β Value for Prostate Tumours Low Enough to be Safely Used in Clinical Trials?Clinical Oncology, 2007
- Use of Individual Fraction Size Data from 3756 Patients to Directly Determine the α/β Ratio of Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- The α/β ratio for prostate cancer: What is it, really?Radiotherapy and Oncology, 2005
- What hypofractionated protocols should be tested for prostate cancer?International Journal of Radiation Oncology*Biology*Physics, 2003
- Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate CancerJournal of Clinical Oncology, 1999
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationshipsInternational Journal of Radiation Oncology*Biology*Physics, 1982